廣田 愛1, 和泉 春香1, 長瀬 大輔1, 入田 博史1, 澁谷 亜紀子1, 三井 ゆりか1, 加藤 元浩1, 倉石 安庸1, 荒井 一歩2, 名取 一彦1 (1.東邦大学 血液・腫瘍科, 2.東邦大学 看護学部)
セッション情報
ポスター
2018年10月14日(日)
ポスター3-20 DLBCL: 臨床
2018年10月14日(日) 13:00 〜 13:40 ポスター会場2 (大阪国際会議場 5F メインホワイエ)
座長:楠本 茂(名古屋市立大学大学院医学研究科 血液・腫瘍内科学)
マーシャル 祥子1, 西村 倫子2, 西原 杏奈2, 井上 典仁2, 草野 善晴2, 三嶋 裕子2, 横山 雅大2, 畠 清彦3, 照井 康仁2 (1.東京女子医大東医療センター 内科, 2.がん研究会有明病院 血液腫瘍科, 3.国際医療福祉大学三田病院 血液内科)
Jeng-Shiun Du1, Hui-Hua Hsiao1,3,4 (1.Department of Internal Medicine, Kaohsiung Medical University Hospital, Kaohsiung, Taiwan, 2.Graduate Institute of Clinical Medicine, Kaohsiung Medical University, Kaohsiung, Taiwan, 3.Faculty of Medicine, Kaohsiung Medical University, Kaohsiung, Taiwan, 4.Department of Laboratory Medicine, Kaohsiung Medical University Hospital, Kaohsiung, Taiwan)
[PS3-20-4] Clinical Outcomes of Addition of High Dose Methotrexate and Cytarabine in DLBCL Treatment
Chee Chean Dang1,2,3, Yong Khee Guan2, Chee Ping Chong3 (1.Pharmacy (Hematology) Hospital Melaka, Melaka, Malaysia, 2.Pantai Hospital, Ayer Keroh, Melaka, Malaysia, 3.Discipline of Clinical Pharmacy, School of Pharmaceutical Sciences, University of Science Malaysia (USM), Penang, Malaysia)
Sayidkhujabek G'olib O'g'li Hoshimov (Hematology, Tashkent Medical Academy, Tashkent, Republic of Uzbekistan)
Ho-Young Yhim1, Sung Kyun Yim1, Yeon-Hee Han2, Myung-Hee Sohn2, Eun-Kee Song1, Chang-Yeol Yim1, Hee Sun Kim3, Jae-Yong Kwak1 (1.Department of Internal Medicine, Chonbuk National University Medical School, Jeonju, Republic of Korea, 2.Department of Nuclear Medicine, Chonbuk National University Medical School, Jeonju, Republic of Korea, 3.College of Nursing, Chonbuk National University, Jeonju, Republic of Korea)
Hee Sang Hwang1, Dok Hyun Yoon2, Jung Yong Hong2, Chan-Sik Park1, Yoon Se Lee3, Young Hyeh Ko4, Seok Jin Kim5, Won Seog Kim5, Cheolwon Suh2, Jooryung Huh1 (1.Department of Pathology, University of Ulsan College of Medicine, Asan Medical Center, Seoul, Republic of Korea, 2.Department of Oncology, University of Ulsan College of Medicine, Asan Medical Center, Seoul, Republic of Korea, 3.Department of Otorhinolaryngology, University of Ulsan College of Medicine, Asan Medical Center, Seoul, Republic of Korea, 4.Department of Pathology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea, 5.Division of Hematology and Oncology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea)
Man Fai Law (Departmetn of Medicine, Prince of Wales Hospital, Shatin, Hong Kong)